Evidence map›Paper›PMID 26369976›Full record

ArticleAntimicrobial agents and chemotherapy2015

In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.

Hamid Badali, Sadegh Khodavaisy, Hamed Fakhim, G Sybren de Hoog, Jacques F Meis, Anuradha Chowdhary

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. First report of a new corneal pathogen: Phaeoacremonium parasiticum.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
  5. The type isolate of a rareMedical mycology case reports · 2020
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hamid BadaliDepartment of Medical Mycology and Parasitology/Invasive Fungi Research Center (IFRC), School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Sadegh KhodavaisyDepartment of Medical Parasitology and Mycology, Kurdistan University of Medical Sciences, Sanandaj, Iran Department of Medical Parasitology and Mycology, Tehran University of Medical Sciences, Tehran, Iran.
Hamed FakhimStudent Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.
G Sybren de HoogCBS-KNAW Fungal Biodiversity Centre, Utrecht, The Netherlands.
Jacques F MeisDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands Department of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands j.meis@cwz.nl.ORCID http://orcid.org/0000-0003-3253-6080
Anuradha ChowdharyDepartment of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.ORCID http://orcid.org/0000-0002-2028-7462

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In vitro susceptibilities of a worldwide collection of molecularly identified Phaeoacremonium strains (n = 43) belonging to seven species and originating from human and environmental sources were determined for eight antifungal drugs. Voriconazole had the lowest geometric mean MIC (0.35 μg/ml), followed by posaconazole (0.37 μg/ml), amphotericin B (0.4 μg/ml), and isavuconazole (1.16 μg/ml). Caspofungin, anidulafungin, fluconazole, and itraconazole had no activity.

Indexed as

Amphotericin BAnidulafunginAntifungal AgentsAscomycotaCaspofunginEchinocandinsFluconazoleHumansItraconazoleLipopeptidesMicrobial Sensitivity TestsMycosesNitrilesPyridinesTriazolesVoriconazoleAmphotericin BAnidulafunginAntifungal AgentsCaspofunginEchinocandinsFluconazoleisavuconazoleItraconazoleLipopeptidesNitrilesposaconazolePyridinesTriazolesVoriconazole

Identifiers

PMID26369976
PMCPMC4649167

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.